These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 16211048

  • 1. Biotech patenting slows in 2004.
    Lawrence S.
    Nat Biotechnol; 2005 Oct; 23(10):1198. PubMed ID: 16211048
    [No Abstract] [Full Text] [Related]

  • 2. Biotech patenting matures.
    Lawrence S.
    Nat Biotechnol; 2004 Oct; 22(10):1202. PubMed ID: 15470446
    [No Abstract] [Full Text] [Related]

  • 3. Insights into US public biotech sector using patenting trends.
    Aggarwal S, Gupta V, Bagchi-Sen S.
    Nat Biotechnol; 2006 Jun; 24(6):643-51. PubMed ID: 16763590
    [Abstract] [Full Text] [Related]

  • 4. Patent drop reveals pressures on industry.
    Lawrence S.
    Nat Biotechnol; 2004 Aug; 22(8):930-1. PubMed ID: 15286630
    [No Abstract] [Full Text] [Related]

  • 5. Biotech patenting upturn.
    Lawrence S.
    Nat Biotechnol; 2006 Oct; 24(10):1190. PubMed ID: 17033646
    [No Abstract] [Full Text] [Related]

  • 6. Patent holdings of US biotherapeutic companies in major markets.
    Sebastian TE, Yerram CB, Saberwal G.
    Drug Discov Today; 2009 May; 14(9-10):442-5. PubMed ID: 19429502
    [Abstract] [Full Text] [Related]

  • 7. Biotech on the rise: diabetes.
    Leewe J.
    Biotechnol J; 2009 Feb; 4(2):172-3. PubMed ID: 19226551
    [No Abstract] [Full Text] [Related]

  • 8. The biotech drug market.
    Lawrence S.
    Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645
    [No Abstract] [Full Text] [Related]

  • 9. Pipelines turn to biotech.
    Lawrence S.
    Nat Biotechnol; 2007 Dec; 25(12):1342. PubMed ID: 18066015
    [No Abstract] [Full Text] [Related]

  • 10. State of biotech sector--2005.
    Lawrence S.
    Nat Biotechnol; 2006 Jun; 24(6):603. PubMed ID: 16763577
    [No Abstract] [Full Text] [Related]

  • 11. Private biotech 2004--the numbers.
    Hodgson J.
    Nat Biotechnol; 2006 Jun; 24(6):635-41. PubMed ID: 16763589
    [Abstract] [Full Text] [Related]

  • 12. Public biotechnology 2005--the numbers.
    Lähteenmäki R, Lawrence S.
    Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
    [Abstract] [Full Text] [Related]

  • 13. Biotech as Bush bows out.
    Lorenzo A.
    Nat Biotechnol; 2008 Jan; 26(1):15-8. PubMed ID: 18183006
    [No Abstract] [Full Text] [Related]

  • 14. Public biotech 2006 - the numbers.
    Lähteenmäki R, Lawrence S.
    Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
    [No Abstract] [Full Text] [Related]

  • 15. Biotech slumps in Q1.
    Lawrence S.
    Nat Biotechnol; 2008 May; 26(5):486. PubMed ID: 18464769
    [No Abstract] [Full Text] [Related]

  • 16. Overcoming the challenges in the pharma/biotech industry.
    Graul AI, Prous JR.
    Drug News Perspect; 2007 May; 20(1):57-68. PubMed ID: 17332900
    [Abstract] [Full Text] [Related]

  • 17. Biotech patents still strong.
    Lawrence S.
    Nat Biotechnol; 2007 Dec; 25(12):1341. PubMed ID: 18066014
    [No Abstract] [Full Text] [Related]

  • 18. Biotech drug market steadily expands.
    Lawrence S.
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract] [Full Text] [Related]

  • 19. University biotech patenting 2013.
    Huggett B, Paisner K.
    Nat Biotechnol; 2014 Jun; 32(6):512. PubMed ID: 24911487
    [No Abstract] [Full Text] [Related]

  • 20. 2007--a banner year for biotech.
    Lawrence S.
    Nat Biotechnol; 2008 Feb; 26(2):150. PubMed ID: 18259162
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.